|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.3 GBX | -5.49% |
|
-5.49% | -40.69% |
| Apr. 26 | EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany | AN |
| Apr. 26 | Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35 | MT |
(via NewsDirect)
Reginald explains the rationale for the decision, before going to explain what each of the three-strong team will bring to Roquefort as it heads toward what he calls “key pre-clinical milestones”.
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| -40.69% | 7.39M | |
| +0.29% | 119B | |
| +15.22% | 67.3B | |
| +18.97% | 63.09B | |
| +12.58% | 43.64B | |
| +15.11% | 43.24B | |
| +22.47% | 35.8B | |
| +6.68% | 25.54B | |
| -0.13% | 23.06B | |
| +7.37% | 19.73B |
ROQUEFORT THERAPEUTICS PLC 
